866-997-4948(US-Canada Toll Free)

EMEA (Europe, Middle East and Africa) Competent Cells Market Report 2017

Published By :

QYResearch

Published Date : Aug 2017

Category :

Pharmaceutical

No. of Pages : 122 Pages

In this report, the EMEA Competent Cells market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.



Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Competent Cells for these regions, from 2012 to 2022 (forecast)

Europe: Germany, France, UK, Russia, Italy and Benelux;

Middle East: Saudi Arabia, Israel, UAE and Iran;

Africa: South Africa, Nigeria, Egypt and Algeria.



EMEA Competent Cells market competition by top manufacturers/players, with Competent Cells sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

Merck KGaA (Germany)

Promega Corporation (U.S.)

Thermo Fisher Scientific, Inc. (U.S)

New England Biolabs (U.S.)

Takara Bio (Japan)

Agilent Technologies (U.S.)

Lucigen (U.S.)

QIAGEN N.V. (Germany)

OriGene Technologies (U.S.)

Bioline (U.K.)

Zymo Research (U.S.)

Beijing TransGen Biotech Co., Ltd. (China)

Source BioScience (U.K.)

IBA GmBH (Germany)

Genewiz (U.S.)

BioDynamics Laboratory, Inc. (Japan)

GCC Biotech (India)

SMOBIO Technology (Taiwan)

GeneScript Corporation (U.S.)

Bio-Rad Laboratories (U.S.)

Life Technologies (India) Pvt. Ltd.

Cell Applications, Inc. (U.S.)

Delphi Genetics (Belgium)

Scarab Genomics, LLC (U.S.)

Yeastern Biotech Co., Ltd. (Taiwan)



On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

Chemically Competent Cells

Electrocompetent Cells



On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Competent Cells for each application, including

Pharmaceutical and Biotechnology Companies

Academic Research Institutes

Contract Research Organizations (CROs)



If you have any special requirements, please let us know and we will offer you the report as you want.



Table of Contents

EMEA (Europe, Middle East and Africa) Competent Cells Market Report 2017
1 Competent Cells Overview
1.1 Product Overview and Scope of Competent Cells
1.2 Classification of Competent Cells
1.2.1 EMEA Competent Cells Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 EMEA Competent Cells Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Chemically Competent Cells
1.2.4 Electrocompetent Cells
1.3 EMEA Competent Cells Market by Application/End Users
1.3.1 EMEA Competent Cells Sales (Volume) and Market Share Comparison by Application (2012-2022
1.3.2 Pharmaceutical and Biotechnology Companies
1.3.3 Academic Research Institutes
1.3.4 Contract Research Organizations (CROs)
1.4 EMEA Competent Cells Market by Region
1.4.1 EMEA Competent Cells Market Size (Value) Comparison by Region (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 Middle East Status and Prospect (2012-2022)
1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Competent Cells (2012-2022)
1.5.1 EMEA Competent Cells Sales and Growth Rate (2012-2022)
1.5.2 EMEA Competent Cells Revenue and Growth Rate (2012-2022)

2 EMEA Competent Cells Competition by Manufacturers/Players/Suppliers, Region, Type and Application
2.1 EMEA Competent Cells Market Competition by Players/Manufacturers
2.1.1 EMEA Competent Cells Sales Volume and Market Share of Major Players (2012-2017)
2.1.2 EMEA Competent Cells Revenue and Share by Players (2012-2017)
2.1.3 EMEA Competent Cells Sale Price by Players (2012-2017)
2.2 EMEA Competent Cells (Volume and Value) by Type/Product Category
2.2.1 EMEA Competent Cells Sales and Market Share by Type (2012-2017)
2.2.2 EMEA Competent Cells Revenue and Market Share by Type (2012-2017)
2.2.3 EMEA Competent Cells Sale Price by Type (2012-2017)
2.3 EMEA Competent Cells (Volume) by Application
2.4 EMEA Competent Cells (Volume and Value) by Region
2.4.1 EMEA Competent Cells Sales and Market Share by Region (2012-2017)
2.4.2 EMEA Competent Cells Revenue and Market Share by Region (2012-2017)
2.4.3 EMEA Competent Cells Sales Price by Region (2012-2017)

3 Europe Competent Cells (Volume, Value and Sales Price), by Players, Countries, Type and Application
3.1 Europe Competent Cells Sales and Value (2012-2017)
3.1.1 Europe Competent Cells Sales Volume and Growth Rate (2012-2017)
3.1.2 Europe Competent Cells Revenue and Growth Rate (2012-2017)
3.2 Europe Competent Cells Sales and Market Share by Type
3.3 Europe Competent Cells Sales and Market Share by Application
3.4 Europe Competent Cells Sales Volume and Value (Revenue) by Countries
3.4.1 Europe Competent Cells Sales Volume by Countries (2012-2017)
3.4.2 Europe Competent Cells Revenue by Countries (2012-2017)
3.4.3 Germany Competent Cells Sales and Growth Rate (2012-2017)
3.4.4 France Competent Cells Sales and Growth Rate (2012-2017)
3.4.5 UK Competent Cells Sales and Growth Rate (2012-2017)
3.4.6 Russia Competent Cells Sales and Growth Rate (2012-2017)
3.4.7 Italy Competent Cells Sales and Growth Rate (2012-2017)
3.4.8 Benelux Competent Cells Sales and Growth Rate (2012-2017)

4 Middle East Competent Cells (Volume, Value and Sales Price), by Region, Type and Application
4.1 Middle East Competent Cells Sales and Value (2012-2017)
4.1.1 Middle East Competent Cells Sales Volume and Growth Rate (2012-2017)
4.1.2 Middle East Competent Cells Revenue and Growth Rate (2012-2017)
4.2 Middle East Competent Cells Sales and Market Share by Type
4.3 Middle East Competent Cells Sales and Market Share by Application
4.4 Middle East Competent Cells Sales Volume and Value (Revenue) by Countries
4.4.1 Middle East Competent Cells Sales Volume by Countries (2012-2017)
4.4.2 Middle East Competent Cells Revenue by Countries (2012-2017)
4.4.3 Saudi Arabia Competent Cells Sales and Growth Rate (2012-2017)
4.4.4 Israel Competent Cells Sales and Growth Rate (2012-2017)
4.4.5 UAE Competent Cells Sales and Growth Rate (2012-2017)
4.4.6 Iran Competent Cells Sales and Growth Rate (2012-2017)

5 Africa Competent Cells (Volume, Value and Sales Price) by Players, Countries, Type and Application
5.1 Africa Competent Cells Sales and Value (2012-2017)
5.1.1 Africa Competent Cells Sales Volume and Growth Rate (2012-2017)
5.1.2 Africa Competent Cells Revenue and Growth Rate (2012-2017)
5.2 Africa Competent Cells Sales and Market Share by Type
5.3 Africa Competent Cells Sales and Market Share by Application
5.4 Africa Competent Cells Sales Volume and Value (Revenue) by Countries
5.4.1 Africa Competent Cells Sales Volume by Countries (2012-2017)
5.4.2 Africa Competent Cells Revenue by Countries (2012-2017)
5.4.3 South Africa Competent Cells Sales and Growth Rate (2012-2017)
5.4.4 Nigeria Competent Cells Sales and Growth Rate (2012-2017)
5.4.5 Egypt Competent Cells Sales and Growth Rate (2012-2017)
5.4.6 Algeria Competent Cells Sales and Growth Rate (2012-2017)

6 EMEA Competent Cells Manufacturers/Players Profiles and Sales Data
6.1 Merck KGaA (Germany)
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Competent Cells Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Merck KGaA (Germany) Competent Cells Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Promega Corporation (U.S.)
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Competent Cells Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Promega Corporation (U.S.) Competent Cells Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Thermo Fisher Scientific, Inc. (U.S)
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Competent Cells Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Thermo Fisher Scientific, Inc. (U.S) Competent Cells Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 New England Biolabs (U.S.)
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Competent Cells Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 New England Biolabs (U.S.) Competent Cells Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Takara Bio (Japan)
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Competent Cells Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Takara Bio (Japan) Competent Cells Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Agilent Technologies (U.S.)
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Competent Cells Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Agilent Technologies (U.S.) Competent Cells Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Lucigen (U.S.)
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Competent Cells Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Lucigen (U.S.) Competent Cells Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 QIAGEN N.V. (Germany)
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Competent Cells Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 QIAGEN N.V. (Germany) Competent Cells Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 OriGene Technologies (U.S.)
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Competent Cells Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 OriGene Technologies (U.S.) Competent Cells Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Bioline (U.K.)
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Competent Cells Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Bioline (U.K.) Competent Cells Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Zymo Research (U.S.)
6.12 Beijing TransGen Biotech Co., Ltd. (China)
6.13 Source BioScience (U.K.)
6.14 IBA GmBH (Germany)
6.15 Genewiz (U.S.)
6.16 BioDynamics Laboratory, Inc. (Japan)
6.17 GCC Biotech (India)
6.18 SMOBIO Technology (Taiwan)
6.19 GeneScript Corporation (U.S.)
6.20 Bio-Rad Laboratories (U.S.)
6.21 Life Technologies (India) Pvt. Ltd.
6.22 Cell Applications, Inc. (U.S.)
6.23 Delphi Genetics (Belgium)
6.24 Scarab Genomics, LLC (U.S.)
6.25 Yeastern Biotech Co., Ltd. (Taiwan)

7 Competent Cells Manufacturing Cost Analysis
7.1 Competent Cells Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Competent Cells

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Competent Cells Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Competent Cells Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA Competent Cells Market Forecast (2017-2022)
11.1 EMEA Competent Cells Sales, Revenue and Price Forecast (2017-2022)
11.1.1 EMEA Competent Cells Sales and Growth Rate Forecast (2017-2022)
11.1.2 EMEA Competent Cells Revenue and Growth Rate Forecast (2017-2022)
11.1.3 EMEA Competent Cells Price and Trend Forecast (2017-2022)
11.2 EMEA Competent Cells Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Competent Cells Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Competent Cells Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Competent Cells Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Competent Cells Sales Forecast by Type (2017-2022)
11.7 EMEA Competent Cells Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


List of Table

List of Tables and Figures

Figure Product Picture of Competent Cells
Figure EMEA Competent Cells Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Competent Cells Sales Volume Market Share by Type (Product Category) in 2016
Figure Chemically Competent Cells Product Picture
Figure Electrocompetent Cells Product Picture
Figure EMEA Competent Cells Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Competent Cells by Application in 2016
Figure Pharmaceutical and Biotechnology Companies Examples
Table Key Downstream Customer in Pharmaceutical and Biotechnology Companies
Figure Academic Research Institutes Examples
Table Key Downstream Customer in Academic Research Institutes
Figure Contract Research Organizations (CROs) Examples
Table Key Downstream Customer in Contract Research Organizations (CROs)
Figure EMEA Competent Cells Market Size (Million USD) by Region (2012-2022)
Figure Europe Competent Cells Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Competent Cells Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Competent Cells Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Competent Cells Revenue (Million USD) Status and Forecast by Countries
Figure Africa Competent Cells Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Competent Cells Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Competent Cells Sales Volume and Growth Rate (2012-2022)
Figure EMEA Competent Cells Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Competent Cells Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Competent Cells Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Competent Cells Sales Share by Players (2012-2017)
Figure 2016 Competent Cells Sales Share by Players
Figure 2017 Competent Cells Sales Share by Players
Figure EMEA Competent Cells Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Competent Cells Revenue (Million USD) by Players (2012-2017)
Table EMEA Competent Cells Revenue Share by Players (2012-2017)
Table 2016 EMEA Competent Cells Revenue Share by Players
Table 2017 EMEA Competent Cells Revenue Share by Players
Table EMEA Competent Cells Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Competent Cells Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Competent Cells Sales Share by Type (2012-2017)
Figure Sales Market Share of Competent Cells by Type (2012-2017)
Figure EMEA Competent Cells Sales Market Share by Type (2012-2017)
Table EMEA Competent Cells Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Competent Cells Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Competent Cells by Type in 2016
Table EMEA Competent Cells Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Competent Cells Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Competent Cells Sales Share by Application (2012-2017)
Figure Sales Market Share of Competent Cells by Application (2012-2017)
Figure EMEA Competent Cells Sales Market Share by Application in 2016
Table EMEA Competent Cells Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Competent Cells Sales Share by Region (2012-2017)
Figure Sales Market Share of Competent Cells by Region (2012-2017)
Figure EMEA Competent Cells Sales Market Share in 2016
Table EMEA Competent Cells Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Competent Cells Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Competent Cells by Region (2012-2017)
Figure EMEA Competent Cells Revenue Market Share Regions in 2016
Table EMEA Competent Cells Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Competent Cells Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Competent Cells Revenue and Growth Rate (2012-2017)
Table Europe Competent Cells Sales (K Units) by Type (2012-2017)
Table Europe Competent Cells Market Share by Type (2012-2017)
Figure Europe Competent Cells Market Share by Type in 2016
Table Europe Competent Cells Sales (K Units) by Application (2012-2017)
Table Europe Competent Cells Market Share by Application (2012-2017)
Figure Europe Competent Cells Market Share by Application in 2016
Table Europe Competent Cells Sales (K Units) by Countries (2012-2017)
Table Europe Competent Cells Sales Market Share by Countries (2012-2017)
Figure Europe Competent Cells Sales Market Share by Countries (2012-2017)
Figure Europe Competent Cells Sales Market Share by Countries in 2016
Table Europe Competent Cells Revenue (Million USD) by Countries (2012-2017)
Table Europe Competent Cells Revenue Market Share by Countries (2012-2017)
Figure Europe Competent Cells Revenue Market Share by Countries (2012-2017)
Figure Europe Competent Cells Revenue Market Share by Countries in 2016
Figure Germany Competent Cells Sales (K Units) and Growth Rate (2012-2017)
Figure France Competent Cells Sales (K Units) and Growth Rate (2012-2017)
Figure UK Competent Cells Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Competent Cells Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Competent Cells Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Competent Cells Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Competent Cells Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Competent Cells Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Competent Cells Sales (K Units) by Type (2012-2017)
Table Middle East Competent Cells Market Share by Type (2012-2017)
Figure Middle East Competent Cells Market Share by Type (2012-2017)
Table Middle East Competent Cells Sales (K Units) by Applications (2012-2017)
Table Middle East Competent Cells Market Share by Applications (2012-2017)
Figure Middle East Competent Cells Sales Market Share by Application in 2016
Table Middle East Competent Cells Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Competent Cells Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Competent Cells Sales Volume Market Share by Countries in 2016
Table Middle East Competent Cells Revenue (Million USD) by Countries (2012-2017)
Table Middle East Competent Cells Revenue Market Share by Countries (2012-2017)
Figure Middle East Competent Cells Revenue Market Share by Countries (2012-2017)
Figure Middle East Competent Cells Revenue Market Share by Countries in 2016
Figure Saudi Arabia Competent Cells Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Competent Cells Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Competent Cells Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Competent Cells Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Competent Cells Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Competent Cells Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Competent Cells Sales (K Units) by Type (2012-2017)
Table Africa Competent Cells Sales Market Share by Type (2012-2017)
Figure Africa Competent Cells Sales Market Share by Type (2012-2017)
Figure Africa Competent Cells Sales Market Share by Type in 2016
Table Africa Competent Cells Sales (K Units) by Application (2012-2017)
Table Africa Competent Cells Sales Market Share by Application (2012-2017)
Figure Africa Competent Cells Sales Market Share by Application (2012-2017)
Table Africa Competent Cells Sales Volume (K Units) by Countries (2012-2017)
Table Africa Competent Cells Sales Market Share by Countries (2012-2017)
Figure Africa Competent Cells Sales Market Share by Countries (2012-2017)
Figure Africa Competent Cells Sales Market Share by Countries in 2016
Table Africa Competent Cells Revenue (Million USD) by Countries (2012-2017)
Table Africa Competent Cells Revenue Market Share by Countries (2012-2017)
Figure Africa Competent Cells Revenue Market Share by Countries (2012-2017)
Figure Africa Competent Cells Revenue Market Share by Countries in 2016
Figure South Africa Competent Cells Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Competent Cells Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Competent Cells Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Competent Cells Sales (K Units) and Growth Rate (2012-2017)
Table Merck KGaA (Germany) Competent Cells Basic Information List
Table Merck KGaA (Germany) Competent Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck KGaA (Germany) Competent Cells Sales (K Units) and Growth Rate (2012-2017)
Figure Merck KGaA (Germany) Competent Cells Sales Market Share in EMEA (2012-2017)
Figure Merck KGaA (Germany) Competent Cells Revenue Market Share in EMEA (2012-2017)
Table Promega Corporation (U.S.) Competent Cells Basic Information List
Table Promega Corporation (U.S.) Competent Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Promega Corporation (U.S.) Competent Cells Sales (K Units) and Growth Rate (2012-2017)
Figure Promega Corporation (U.S.) Competent Cells Sales Market Share in EMEA (2012-2017)
Figure Promega Corporation (U.S.) Competent Cells Revenue Market Share in EMEA (2012-2017)
Table Thermo Fisher Scientific, Inc. (U.S) Competent Cells Basic Information List
Table Thermo Fisher Scientific, Inc. (U.S) Competent Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Thermo Fisher Scientific, Inc. (U.S) Competent Cells Sales (K Units) and Growth Rate (2012-2017)
Figure Thermo Fisher Scientific, Inc. (U.S) Competent Cells Sales Market Share in EMEA (2012-2017)
Figure Thermo Fisher Scientific, Inc. (U.S) Competent Cells Revenue Market Share in EMEA (2012-2017)
Table New England Biolabs (U.S.) Competent Cells Basic Information List
Table New England Biolabs (U.S.) Competent Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure New England Biolabs (U.S.) Competent Cells Sales (K Units) and Growth Rate (2012-2017)
Figure New England Biolabs (U.S.) Competent Cells Sales Market Share in EMEA (2012-2017)
Figure New England Biolabs (U.S.) Competent Cells Revenue Market Share in EMEA (2012-2017)
Table Takara Bio (Japan) Competent Cells Basic Information List
Table Takara Bio (Japan) Competent Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Takara Bio (Japan) Competent Cells Sales (K Units) and Growth Rate (2012-2017)
Figure Takara Bio (Japan) Competent Cells Sales Market Share in EMEA (2012-2017)
Figure Takara Bio (Japan) Competent Cells Revenue Market Share in EMEA (2012-2017)
Table Agilent Technologies (U.S.) Competent Cells Basic Information List
Table Agilent Technologies (U.S.) Competent Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Agilent Technologies (U.S.) Competent Cells Sales (K Units) and Growth Rate (2012-2017)
Figure Agilent Technologies (U.S.) Competent Cells Sales Market Share in EMEA (2012-2017)
Figure Agilent Technologies (U.S.) Competent Cells Revenue Market Share in EMEA (2012-2017)
Table Lucigen (U.S.) Competent Cells Basic Information List
Table Lucigen (U.S.) Competent Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Lucigen (U.S.) Competent Cells Sales (K Units) and Growth Rate (2012-2017)
Figure Lucigen (U.S.) Competent Cells Sales Market Share in EMEA (2012-2017)
Figure Lucigen (U.S.) Competent Cells Revenue Market Share in EMEA (2012-2017)
Table QIAGEN N.V. (Germany) Competent Cells Basic Information List
Table QIAGEN N.V. (Germany) Competent Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure QIAGEN N.V. (Germany) Competent Cells Sales (K Units) and Growth Rate (2012-2017)
Figure QIAGEN N.V. (Germany) Competent Cells Sales Market Share in EMEA (2012-2017)
Figure QIAGEN N.V. (Germany) Competent Cells Revenue Market Share in EMEA (2012-2017)
Table OriGene Technologies (U.S.) Competent Cells Basic Information List
Table OriGene Technologies (U.S.) Competent Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure OriGene Technologies (U.S.) Competent Cells Sales (K Units) and Growth Rate (2012-2017)
Figure OriGene Technologies (U.S.) Competent Cells Sales Market Share in EMEA (2012-2017)
Figure OriGene Technologies (U.S.) Competent Cells Revenue Market Share in EMEA (2012-2017)
Table Bioline (U.K.) Competent Cells Basic Information List
Table Bioline (U.K.) Competent Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bioline (U.K.) Competent Cells Sales (K Units) and Growth Rate (2012-2017)
Figure Bioline (U.K.) Competent Cells Sales Market Share in EMEA (2012-2017)
Figure Bioline (U.K.) Competent Cells Revenue Market Share in EMEA (2012-2017)
Table Zymo Research (U.S.) Competent Cells Basic Information List
Table Beijing TransGen Biotech Co., Ltd. (China) Competent Cells Basic Information List
Table Source BioScience (U.K.) Competent Cells Basic Information List
Table IBA GmBH (Germany) Competent Cells Basic Information List
Table Genewiz (U.S.) Competent Cells Basic Information List
Table BioDynamics Laboratory, Inc. (Japan) Competent Cells Basic Information List
Table GCC Biotech (India) Competent Cells Basic Information List
Table SMOBIO Technology (Taiwan) Competent Cells Basic Information List
Table GeneScript Corporation (U.S.) Competent Cells Basic Information List
Table Bio-Rad Laboratories (U.S.) Competent Cells Basic Information List
Table Life Technologies (India) Pvt. Ltd. Competent Cells Basic Information List
Table Cell Applications, Inc. (U.S.) Competent Cells Basic Information List
Table Delphi Genetics (Belgium) Competent Cells Basic Information List
Table Scarab Genomics, LLC (U.S.) Competent Cells Basic Information List
Table Yeastern Biotech Co., Ltd. (Taiwan) Competent Cells Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Competent Cells
Figure Manufacturing Process Analysis of Competent Cells
Figure Competent Cells Industrial Chain Analysis
Table Raw Materials Sources of Competent Cells Major Manufacturers in 2016
Table Major Buyers of Competent Cells
Table Distributors/Traders List
Figure EMEA Competent Cells Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Competent Cells Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Competent Cells Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Competent Cells Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Competent Cells Sales Market Share Forecast by Region (2017-2022)
Table EMEA Competent Cells Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Competent Cells Revenue Market Share Forecast by Region (2017-2022)
Table Europe Competent Cells Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Competent Cells Sales Market Share Forecast by Countries (2017-2022)
Table Europe Competent Cells Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Competent Cells Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Competent Cells Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Competent Cells Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Competent Cells Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Competent Cells Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Competent Cells Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Competent Cells Sales Market Share Forecast by Countries (2017-2022)
Table Africa Competent Cells Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Competent Cells Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Competent Cells Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Competent Cells Sales Market Share Forecast by Type (2017-2022)
Table EMEA Competent Cells Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Competent Cells Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *